TITAN PHARMACEUTICALS INC DE's ticker is and the CUSIP is 888314906. A total of 1 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | -27.7% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $65 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 100 | -96.7% | 0.00% | – |
| Q4 2021 | $3,000 | -78.6% | 3,000 | -61.0% | 0.00% | – |
| Q3 2021 | $14,000 | +40.0% | 7,700 | +108.1% | 0.00% | – |
| Q2 2021 | $10,000 | -61.5% | 3,700 | -57.5% | 0.00% | – |
| Q1 2021 | $26,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |